Triple Threat 45mg Research Pen

What is the Triple Threat 45mg research pen?

The Triple Threat is MyPep Biotech’s 45mg triple-blend research pen. It combines Retatrutide 20mg, Tirzepatide 20mg and Cagrilintide 5mg in a single pre-filled pen, so researchers can study all three compounds together without handling separate vials.

What’s in the Triple Threat pen?

Why researchers are interested in this combination

Retatrutide and Tirzepatide are among the most widely studied incretin peptides in current metabolic research. Cagrilintide works on a different pathway (amylin), which is why amylin and incretin combinations are an active area of published research. The Triple Threat brings all three together in one pen.

Triple Threat pen vs separate vials

• One pen instead of three vials
• Pre-filled, no reconstitution needed
• Easier to store, label and track

Price and UK delivery

£199.99 per 45mg pen. Same-day dispatch on orders before 2pm, Royal Mail Tracked 24, discreet packaging.

Storage

Store at 2°C to 8°C. Keep away from direct light. Do not freeze.

Triple Threat pen FAQs

How much is the Triple Threat pen in the UK?

£199.99 for one 45mg pen, or £159.99 with 20% off when you pre-order on WhatsApp.

What’s in the Triple Threat pen?

Retatrutide 20mg, Tirzepatide 20mg and Cagrilintide 5mg (45mg total).

Is Triple Threat the same as a Retatrutide pen?

No. It contains Retatrutide plus Tirzepatide and Cagrilintide in one pen.

When is the Triple Threat back in stock?

Friday 6th or Saturday 7th November. Pre-order on WhatsApp now and yours is sent first with next-day delivery.

Is it for human use?

No. The Triple Threat is sold strictly for laboratory research use only. Not for human or veterinary use.

For laboratory research use only. Not for human or veterinary use. Keep out of reach of children.